Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Eosinophilic Fasciitis and Common Variable Immunodeficiency: An Unusual Association and Literature Review.

El-Jammal T, Gerfaud-Valentin M, Durupt F, Petiot P, De Parisot A, Streichenberger N, Jamilloux Y, Sève P.

J Allergy Clin Immunol Pract. 2019 Jul 12. pii: S2213-2198(19)30566-5. doi: 10.1016/j.jaip.2019.06.014. [Epub ahead of print] No abstract available.

PMID:
31307966
2.

Isolated Muscular Sarcoidosis Revealed by Hypercalcemia and 18F-FDG PET/CT.

Dhomps A, Foret T, Streichenberger N, Skanjeti A, Tordo J.

Clin Nucl Med. 2019 Oct;44(10):824-825. doi: 10.1097/RLU.0000000000002678.

PMID:
31274562
3.

Dilated cardiomyopathy and limb-girdle muscular dystrophy-dystroglycanopathy due to novel pathogenic variants in the DPM3 gene.

Svahn J, Laforêt P, Vial C, Streichenberger N, Romero N, Bouchet-Séraphin C, Bruneel A, Dupré T, Seta N, Menassa R, Michel-Calemard L, Stojkovic T.

Neuromuscul Disord. 2019 Jul;29(7):497-502. doi: 10.1016/j.nmd.2019.05.004. Epub 2019 May 9.

PMID:
31266720
4.

The standardization of cerebrospinal fluid markers and neuropathological diagnoses brings to light the frequent complexity of concomitant pathology in Alzheimer's disease: The next challenge for biochemical markers?

Fenouil T, Fourier A, Quadrio I, Streichenberger N, Bernardini S, Zima T, Perret-Liaudet A, Meyronet D.

Clin Biochem. 2019 Oct;72:15-23. doi: 10.1016/j.clinbiochem.2019.06.004. Epub 2019 Jun 10. Review.

PMID:
31194969
5.

A Multiplex Quantitative Reverse Transcription Polymerase Chain Reaction Assay for the Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pilocytic Astrocytomas.

Bret D, Chappuis V, Poncet D, Ducray F, Silva K, Mion F, Vasiljevic A, Ferraro-Peyret C, Mottolese C, Leblond P, Gabut M, Frappaz D, Streichenberger N, Meyronet D, Bringuier PP, Barritault M.

Mol Diagn Ther. 2019 Aug;23(4):537-545. doi: 10.1007/s40291-019-00403-3.

PMID:
31087282
6.

Myoglobinopathy is an adult-onset autosomal dominant myopathy with characteristic sarcoplasmic inclusions.

Olivé M, Engvall M, Ravenscroft G, Cabrera-Serrano M, Jiao H, Bortolotti CA, Pignataro M, Lambrughi M, Jiang H, Forrest ARR, Benseny-Cases N, Hofbauer S, Obinger C, Battistuzzi G, Bellei M, Borsari M, Di Rocco G, Viola HM, Hool LC, Cladera J, Lagerstedt-Robinson K, Xiang F, Wredenberg A, Miralles F, Baiges JJ, Malfatti E, Romero NB, Streichenberger N, Vial C, Claeys KG, Straathof CSM, Goris A, Freyer C, Lammens M, Bassez G, Kere J, Clemente P, Sejersen T, Udd B, Vidal N, Ferrer I, Edström L, Wedell A, Laing NG.

Nat Commun. 2019 Mar 27;10(1):1396. doi: 10.1038/s41467-019-09111-2.

7.

Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies.

Hadjadj J, Guffroy A, Delavaud C, Taieb G, Meyts I, Fresard A, Streichenberger N, L'Honneur AS, Rozenberg F, D'Aveni M, Aguilar C, Rosain J, Picard C, Mahlaoui N, Lecuit M, Hermine O, Lortholary O, Suarez F.

J Clin Immunol. 2019 Jan;39(1):55-64. doi: 10.1007/s10875-018-0578-8. Epub 2018 Dec 14.

PMID:
30552536
8.

Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome.

Vogrig A, Joubert B, Maureille A, Thomas L, Bernard E, Streichenberger N, Cotton F, Ducray F, Honnorat J.

J Neurol. 2019 Feb;266(2):398-410. doi: 10.1007/s00415-018-9143-x. Epub 2018 Nov 29.

PMID:
30498914
9.

Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis.

Zhang Q, Duplany A, Moncollin V, Mouradian S, Goillot E, Mazelin L, Gauthier K, Streichenberger N, Angleraux C, Chen J, Ding S, Schaeffer L, Gangloff YG.

J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):35-53. doi: 10.1002/jcsm.12336. Epub 2018 Nov 21.

10.

Pembrolizumab-induced dermatomyositis in a patient with metastatic melanoma.

Berger M, Legeay AL, Souci S, Streichenberger N, Thomas L, Dalle S.

Eur J Cancer. 2018 Nov;104:227-230. doi: 10.1016/j.ejca.2018.08.021. Epub 2018 Oct 12. Review. No abstract available.

PMID:
30322679
11.

Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy.

Lopez-Cuina M, Fernagut PO, Canron MH, Vital A, Lannes B, De Paula AM, Streichenberger N, Guehl D, Damier P, Eusebio A, Houeto JL, Tison F, Tranchant C, Viallet F, Witjas T, Thobois S, Meissner WG.

Neurobiol Dis. 2018 Oct;118:155-160. doi: 10.1016/j.nbd.2018.07.016. Epub 2018 Jul 17.

PMID:
30026036
12.

Task-induced gamma band effect in type II focal cortical dysplasia: An exploratory study.

Souci S, Petton M, Jung J, Bourdillon P, Bouet R, Richard-Mornas A, Streichenberger N, Catenoix H, Montavont A, Isnard J, Guenot M, Kahane P, Lachaux JP, Rheims S.

Epilepsy Behav. 2018 Aug;85:76-84. doi: 10.1016/j.yebeh.2018.05.017. Epub 2018 Jun 14.

PMID:
29909256
13.

Congenital Titinopathy: Comprehensive characterization and pathogenic insights.

Oates EC, Jones KJ, Donkervoort S, Charlton A, Brammah S, Smith JE 3rd, Ware JS, Yau KS, Swanson LC, Whiffin N, Peduto AJ, Bournazos A, Waddell LB, Farrar MA, Sampaio HA, Teoh HL, Lamont PJ, Mowat D, Fitzsimons RB, Corbett AJ, Ryan MM, O'Grady GL, Sandaradura SA, Ghaoui R, Joshi H, Marshall JL, Nolan MA, Kaur S, Punetha J, Töpf A, Harris E, Bakshi M, Genetti CA, Marttila M, Werlauff U, Streichenberger N, Pestronk A, Mazanti I, Pinner JR, Vuillerot C, Grosmann C, Camacho A, Mohassel P, Leach ME, Foley AR, Bharucha-Goebel D, Collins J, Connolly AM, Gilbreath HR, Iannaccone ST, Castro D, Cummings BB, Webster RI, Lazaro L, Vissing J, Coppens S, Deconinck N, Luk HM, Thomas NH, Foulds NC, Illingworth MA, Ellard S, McLean CA, Phadke R, Ravenscroft G, Witting N, Hackman P, Richard I, Cooper ST, Kamsteeg EJ, Hoffman EP, Bushby K, Straub V, Udd B, Ferreiro A, North KN, Clarke NF, Lek M, Beggs AH, Bönnemann CG, MacArthur DG, Granzier H, Davis MR, Laing NG.

Ann Neurol. 2018 Jun;83(6):1105-1124. doi: 10.1002/ana.25241.

14.

SMAD6 overexpression leads to accelerated myogenic differentiation of LMNA mutated cells.

Janin A, Bauer D, Ratti F, Valla C, Bertrand A, Christin E, Chopin E, Streichenberger N, Bonne G, Gache V, Cohen T, Méjat A.

Sci Rep. 2018 Apr 4;8(1):5618. doi: 10.1038/s41598-018-23918-x.

15.

Muscular disorder related to immune checkpoint inhibitors: forewarned is forearmed.

Gallay L, Bourgeois-Vionnet J, Joubert B, Streichenberger N, Hot A.

Neuro Oncol. 2018 May 18;20(6):861-862. doi: 10.1093/neuonc/noy031. No abstract available.

16.

Nivolumab-induced myositis: A case report and a literature review.

Bourgeois-Vionnet J, Joubert B, Bernard E, Sia MA, Pante V, Fabien N, Honnorat J, Streichenberger N.

J Neurol Sci. 2018 Apr 15;387:51-53. doi: 10.1016/j.jns.2018.01.030. Epub 2018 Feb 3. Review. No abstract available.

PMID:
29571871
17.

Focal myositis: New insights on diagnosis and pathology.

Gallay L, Hot A, Petiot P, Thivolet-Bejui F, Maucort-Boulch D, Streichenberger N.

Neurology. 2018 Mar 20;90(12):e1013-e1020. doi: 10.1212/WNL.0000000000005160. Epub 2018 Feb 21.

PMID:
29467303
18.

Clinical heterogeneity and phenotype/genotype findings in 5 families with GYG1 deficiency.

Ben Yaou R, Hubert A, Nelson I, Dahlqvist JR, Gaist D, Streichenberger N, Beuvin M, Krahn M, Petiot P, Parisot F, Michel F, Malfatti E, Romero N, Carlier RY, Eymard B, Labrune P, Duno M, Krag T, Cerino M, Bartoli M, Bonne G, Vissing J, Laforet P, Petit FM.

Neurol Genet. 2017 Dec 18;3(6):e208. doi: 10.1212/NXG.0000000000000208. eCollection 2017 Dec.

19.

Experimental transfusion of variant CJD-infected blood reveals previously uncharacterised prion disorder in mice and macaque.

Comoy EE, Mikol J, Jaffré N, Lebon V, Levavasseur E, Streichenberger N, Sumian C, Perret-Liaudet A, Eloit M, Andreoletti O, Haïk S, Hantraye P, Deslys JP.

Nat Commun. 2017 Nov 2;8(1):1268. doi: 10.1038/s41467-017-01347-0.

20.

[Focal myositis: An unknown disease].

Gallay L, Streichenberger N, Benveniste O, Allenbach Y.

Rev Med Interne. 2017 Oct;38(10):679-684. doi: 10.1016/j.revmed.2017.06.015. Epub 2017 Sep 22. Review. French.

PMID:
28947258
21.

'Prion-like' propagation of the synucleinopathy of M83 transgenic mice depends on the mouse genotype and type of inoculum.

Sargent D, Verchère J, Lazizzera C, Gaillard D, Lakhdar L, Streichenberger N, Morignat E, Bétemps D, Baron T.

J Neurochem. 2017 Oct;143(1):126-135. doi: 10.1111/jnc.14139. Epub 2017 Sep 5. Erratum in: J Neurochem. 2018 Jul;146(2):199.

22.

Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy.

Bauché S, Vellieux G, Sternberg D, Fontenille MJ, De Bruyckere E, Davoine CS, Brochier G, Messéant J, Wolf L, Fardeau M, Lacène E, Romero N, Koenig J, Fournier E, Hantaï D, Streichenberger N, Manel V, Lacour A, Nadaj-Pakleza A, Sukno S, Bouhour F, Laforêt P, Fontaine B, Strochlic L, Eymard B, Chevessier F, Stojkovic T, Nicole S.

J Neurol. 2017 Aug;264(8):1791-1803. doi: 10.1007/s00415-017-8569-x. Epub 2017 Jul 15.

PMID:
28712002
23.

Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.

Biancalana V, Scheidecker S, Miguet M, Laquerrière A, Romero NB, Stojkovic T, Abath Neto O, Mercier S, Voermans N, Tanner L, Rogers C, Ollagnon-Roman E, Roper H, Boutte C, Ben-Shachar S, Lornage X, Vasli N, Schaefer E, Laforet P, Pouget J, Moerman A, Pasquier L, Marcorelle P, Magot A, Küsters B, Streichenberger N, Tranchant C, Dondaine N, Schneider R, Gasnier C, Calmels N, Kremer V, Nguyen K, Perrier J, Kamsteeg EJ, Carlier P, Carlier RY, Thompson J, Boland A, Deleuze JF, Fardeau M, Zanoteli E, Eymard B, Laporte J.

Acta Neuropathol. 2017 Dec;134(6):889-904. doi: 10.1007/s00401-017-1748-0. Epub 2017 Jul 6.

PMID:
28685322
24.

Altered Ca2+ homeostasis induces Calpain-Cathepsin axis activation in sporadic Creutzfeldt-Jakob disease.

Llorens F, Thüne K, Sikorska B, Schmitz M, Tahir W, Fernández-Borges N, Cramm M, Gotzmann N, Carmona M, Streichenberger N, Michel U, Zafar S, Schuetz AL, Rajput A, Andréoletti O, Bonn S, Fischer A, Liberski PP, Torres JM, Ferrer I, Zerr I.

Acta Neuropathol Commun. 2017 Apr 27;5(1):35. doi: 10.1186/s40478-017-0431-y.

25.

Truncating mutations on myofibrillar myopathies causing genes as prevalent molecular explanations on patients with dilated cardiomyopathy.

Janin A, N'Guyen K, Habib G, Dauphin C, Chanavat V, Bouvagnet P, Eschalier R, Streichenberger N, Chevalier P, Millat G.

Clin Genet. 2017 Dec;92(6):616-623. doi: 10.1111/cge.13043. Epub 2017 May 18.

PMID:
28436997
26.

[Unusual phenotype of myopathy associated with a new PNPLA2 mutation].

Jousserand G, Streichenberger N, Petiot P.

Med Sci (Paris). 2016 Nov;32 Hors série n°2:10-11. Epub 2016 Nov 21. French. No abstract available.

27.

Focal myositis: A review.

Devic P, Gallay L, Streichenberger N, Petiot P.

Neuromuscul Disord. 2016 Nov;26(11):725-733. doi: 10.1016/j.nmd.2016.08.014. Epub 2016 Aug 26. Review.

PMID:
27726926
28.

SWORD: A simplified desensitization protocol for enzyme replacement therapy in adult Pompe disease.

Gallay L, Petiot P, Durieu I, Streichenberger N, Berard F.

Neuromuscul Disord. 2016 Nov;26(11):801-804. doi: 10.1016/j.nmd.2016.07.006. Epub 2016 Jul 19.

PMID:
27637292
29.

Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment.

Maroui MA, Callé A, Cohen C, Streichenberger N, Texier P, Takissian J, Rousseau A, Poccardi N, Welsch J, Corpet A, Schaeffer L, Labetoulle M, Lomonte P.

PLoS Pathog. 2016 Sep 12;12(9):e1005834. doi: 10.1371/journal.ppat.1005834. eCollection 2016 Sep.

30.

Tau pathology in Creutzfeldt-Jakob disease revisited.

Kovacs GG, Rahimi J, Ströbel T, Lutz MI, Regelsberger G, Streichenberger N, Perret-Liaudet A, Höftberger R, Liberski PP, Budka H, Sikorska B.

Brain Pathol. 2017 May;27(3):332-344. doi: 10.1111/bpa.12411. Epub 2016 Aug 2.

PMID:
27377321
31.

Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals.

Vidal B, Sebti J, Verdurand M, Fieux S, Billard T, Streichenberger N, Troakes C, Newman-Tancredi A, Zimmer L.

Neuropharmacology. 2016 Oct;109:88-95. doi: 10.1016/j.neuropharm.2016.05.009. Epub 2016 May 13.

PMID:
27183968
32.

Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease.

Béhin A, Acquaviva-Bourdain C, Souvannanorath S, Streichenberger N, Attarian S, Bassez G, Brivet M, Fouilhoux A, Labarre-Villa A, Laquerrière A, Pérard L, Kaminsky P, Pouget J, Rigal O, Vanhulle C, Eymard B, Vianey-Saban C, Laforêt P.

Rev Neurol (Paris). 2016 Mar;172(3):231-41. doi: 10.1016/j.neurol.2015.11.008. Epub 2016 Mar 30.

PMID:
27038534
33.

Outcome of deep brain stimulation in slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature.

Meissner WG, Laurencin C, Tranchant C, Witjas T, Viallet F, Guehl D, Damier P, Houeto JL, Tison F, Eusebio A, Vital A, Streichenberger N, Lannes B, Maues de Paula A, Thobois S.

Parkinsonism Relat Disord. 2016 Mar;24:69-75. doi: 10.1016/j.parkreldis.2016.01.005. Epub 2016 Jan 7. Review.

PMID:
26778473
34.

Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.

Picard C, Vincent T, Lega JC, Hue S, Fortenfant F, Lakomy D, Humbel RL, Goetz J, Molinari N, Bardin N, Bertin D, Johanet C, Chretien P, Dubucquoi S, Streichenberger N, Desplat-Jégo S, Bossuyt X, Sibilia J, Abreu I, Chevailler A, Fabien N.

Immunol Res. 2016 Jun;64(3):677-86. doi: 10.1007/s12026-015-8774-6.

PMID:
26744256
35.

Significant response to immune therapies in a case of subacute necrotizing myopathy and FKRP mutations.

Svahn J, Streichenberger N, Benveniste O, Menassa R, Michel L, Fayolle H, Petiot P.

Neuromuscul Disord. 2015 Nov;25(11):865-8. doi: 10.1016/j.nmd.2015.08.009. Epub 2015 Aug 21.

PMID:
26363967
36.

Ultra-structural time-course study in the C. elegans model for Duchenne muscular dystrophy highlights a crucial role for sarcomere-anchoring structures and sarcolemma integrity in the earliest steps of the muscle degeneration process.

Brouilly N, Lecroisey C, Martin E, Pierson L, Mariol MC, Qadota H, Labouesse M, Streichenberger N, Mounier N, Gieseler K.

Hum Mol Genet. 2015 Nov 15;24(22):6428-45. doi: 10.1093/hmg/ddv353. Epub 2015 Sep 10.

PMID:
26358775
37.

A splicing mutation in the DMD gene detected by next-generation sequencing and confirmed by mRNA and protein analysis.

Roucher Boulez F, Menassa R, Streichenberger N, Manel V, Mallet-Motak D, Morel Y, Michel-Calemard L.

Clin Chim Acta. 2015 Aug 25;448:146-9. doi: 10.1016/j.cca.2015.07.002. Epub 2015 Jul 3.

PMID:
26148721
38.

The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study.

Meyronet D, Dorey A, Massoma P, Rey C, Alix E, Silva K, Perrin C, Quadrio I, Perret-Liaudet A, Streichenberger N, Thomasset N, Honnorat J, Arzberger T, Kretzschmar H.

J Neural Transm (Vienna). 2015 Jul;122(7):975-91. doi: 10.1007/s00702-015-1378-4. Epub 2015 May 16.

PMID:
25976431
39.

Severe osteomalacia mimicking progressive myopathy.

Benhamou J, Fontanges E, Streichenberger N, Petiot P.

Int J Rheum Dis. 2017 Nov;20(11):1803-1804. doi: 10.1111/1756-185X.12641. Epub 2015 May 11. No abstract available.

PMID:
25958779
40.

BrainNet Europe's Code of Conduct for brain banking.

Klioueva NM, Rademaker MC, Dexter DT, Al-Sarraj S, Seilhean D, Streichenberger N, Schmitz P, Bell JE, Ironside JW, Arzberger T, Huitinga I.

J Neural Transm (Vienna). 2015 Jul;122(7):937-40. doi: 10.1007/s00702-014-1353-5. Epub 2015 Jan 13.

41.

Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.

Dorey A, Tholance Y, Vighetto A, Perret-Liaudet A, Lachman I, Krolak-Salmon P, Wagner U, Struyfs H, De Deyn PP, El-Moualij B, Zorzi W, Meyronet D, Streichenberger N, Engelborghs S, Kovacs GG, Quadrio I.

JAMA Neurol. 2015 Mar;72(3):267-75. doi: 10.1001/jamaneurol.2014.4068.

PMID:
25559883
42.

Histone deacetylase 6 is a FoxO transcription factor-dependent effector in skeletal muscle atrophy.

Ratti F, Ramond F, Moncollin V, Simonet T, Milan G, Méjat A, Thomas JL, Streichenberger N, Gilquin B, Matthias P, Khochbin S, Sandri M, Schaeffer L.

J Biol Chem. 2015 Feb 13;290(7):4215-24. doi: 10.1074/jbc.M114.600916. Epub 2014 Dec 15.

43.

Spinocerebellar ataxia type 36 exists in diverse populations and can be caused by a short hexanucleotide GGCCTG repeat expansion.

Obayashi M, Stevanin G, Synofzik M, Monin ML, Duyckaerts C, Sato N, Streichenberger N, Vighetto A, Desestret V, Tesson C, Wichmann HE, Illig T, Huttenlocher J, Kita Y, Izumi Y, Mizusawa H, Schöls L, Klopstock T, Brice A, Ishikawa K, Dürr A.

J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):986-95. doi: 10.1136/jnnp-2014-309153. Epub 2014 Dec 4.

PMID:
25476002
44.

Erratum to: Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium.

Alafuzoff I, Pikkarainen M, Neumann M, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Ince PG, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Nilsson T, Parchi P, Patsouris E, Revesz T, Roggendorf W, Rozemuller A, Seilhean D, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H.

J Neural Transm (Vienna). 2015 Jul;122(7):973-4. doi: 10.1007/s00702-014-1337-5. No abstract available.

PMID:
25418279
45.

COB231 targets amyloid plaques in post-mortem human brain tissue and in an Alzheimer mouse model.

Garin D, Virgone-Carlotta A, Gözel B, Oukhatar F, Perret P, Marti-Battle D, Touret M, Millet P, Dubois-Dauphin M, Meyronet D, Streichenberger N, Laferla FM, Demeunynck M, Chierici S, Sallanon Moulin M, Ghezzi C.

J Neurochem. 2015 Mar;132(5):609-18.

46.

Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium.

Alafuzoff I, Pikkarainen M, Neumann M, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Ince PG, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Nilsson T, Parchi P, Patsouris E, Revesz T, Roggendorf W, Rozemuller A, Seilhean D, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H.

J Neural Transm (Vienna). 2015 Jul;122(7):957-72. doi: 10.1007/s00702-014-1304-1. Epub 2014 Sep 20. Erratum in: J Neural Transm (Vienna). 2015 Jul;122(7):973-4.

47.

A postmortem study to compare agonist and antagonist 5-HT1A receptor-binding sites in Alzheimer's disease.

Becker G, Streichenberger N, Billard T, Newman-Tancredi A, Zimmer L.

CNS Neurosci Ther. 2014 Oct;20(10):930-4. doi: 10.1111/cns.12306. Epub 2014 Jul 9.

48.

Preclinical detection of variant CJD and BSE prions in blood.

Lacroux C, Comoy E, Moudjou M, Perret-Liaudet A, Lugan S, Litaise C, Simmons H, Jas-Duval C, Lantier I, Béringue V, Groschup M, Fichet G, Costes P, Streichenberger N, Lantier F, Deslys JP, Vilette D, Andréoletti O.

PLoS Pathog. 2014 Jun 12;10(6):e1004202. doi: 10.1371/journal.ppat.1004202. eCollection 2014 Jun.

49.

Phosphorylation of NBR1 by GSK3 modulates protein aggregation.

Nicot AS, Lo Verso F, Ratti F, Pilot-Storck F, Streichenberger N, Sandri M, Schaeffer L, Goillot E.

Autophagy. 2014 Jun;10(6):1036-53. doi: 10.4161/auto.28479.

50.

Accuracy of distinguishing between dysembryoplastic neuroepithelial tumors and other epileptogenic brain neoplasms with [¹¹C]methionine PET.

Rheims S, Rubi S, Bouvard S, Bernard E, Streichenberger N, Guenot M, Le Bars D, Hammers A, Ryvlin P.

Neuro Oncol. 2014 Oct;16(10):1417-26. doi: 10.1093/neuonc/nou022. Epub 2014 Mar 5.

Supplemental Content

Loading ...
Support Center